Behavioral and antiepileptic effect of acute administration of the extract of the aquatic plant Echinodorus berteroi (Sprengel) Fassett (upright burhead)

Epilepsy and Behavior

Volumn 9, Issue 1, 2006, Pages 40-45

  Buznego, María T ^a   Pérez Saad, Héctor ^a  

^a INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

Author keywords

Amphetamine stereotypy; Echinodorus berteroi; Electroshock; Epilepsy; Exploratory behavior; Irwin test; Isoniazid; Penicillin focus; Picrotoxin

Indexed keywords

AMPHETAMINE; CURARE; DIAZEPAM; ECHINODORUS BERTEROI EXTRACT; HALOPERIDOL; ISONIAZID; PENICILLIN G; PICROTOXIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR DISORDER; CLONIC SEIZURE; CONTROLLED STUDY; ECHINODORUS BERTEROI; EPILEPSY; HYPERACTIVITY; LATENT PERIOD; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANT ROOT; RAT; SENSORIMOTOR CORTEX; SPIKE WAVE; STEREOTYPY; SURVIVAL TIME;

ALISMATACEAE; ANIMALS; CENTRAL NERVOUS SYSTEM; CONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; ELECTROSHOCK; EPILEPSY; ISONIAZID; MALE; MICE; MICE, INBRED STRAINS; MUSCLE HYPOTONIA; PENICILLINS; PHYTOTHERAPY; PICROTOXIN; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR;

EID: 33745842901     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.03.015     Document Type: Article

References (27)

1. Rogers G.K. The genera of Alismataceae in the southeastern United States. J Arnold Arbor 64 (1983) 383-420
2. Fassett N.C. Echinodorus in the American tropics. Rhodora 57 (1955) 133-156 174-88, 202-12
3. Haynes R.R., and Holm-Nielsen L.B. Notes on Echinodorus (Alismataceae). Brittonia 38 (1986) 325-332
4. Roig J.T. Llantén cimarrón. In: Roig J. (Ed). Plantas Medicinales, Aromáticas o Venenosas de Cuba (1988), Científico-Técnica, Havana 572-573
5. Buznego M.T., Acevedo M.E., León N., et al. Perfil neurofarmacológico de Echinodorus berteroi (Spreng.) Fasset var. berteroi (llantén cimarrón). Rev Cub Plant Med 3 (1998) 42-45
6. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacology 13 (1978) 222-257
7. Archer J. Test for emotionality in rats and mice: a review. Anim Behav 21 (1973) 205-235
8. Choleris E., Thomas A.W., Kavaliers M., et al. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev 25 (2001) 235-260
9. Poleszak E., and Malec D. Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats. Pol J Pharmacol 52 (2000) 423-429
10. Bernasconi R., Klein M., Martin P., et al. The specific protective effect of diazepam and valproate against isoniazid-induced seizures is not correlated with increased GABA levels. J Neurol Transm 63 (1985) 169-189
11. Voghel H.G., and Voghel W.H. Psychotropic and neurotropic activity. In: Voghel H.G., and Voghel W.H. (Eds). Drugs discovery and evaluation: pharmacological assays (1997), Springer-Verlag, Berlin 204-315
12. Browning R.A. The role of neurotransmitter in electroshock seizure models. In: Jobe P.C., and Laird H.E. (Eds). Neurotransmitter systems and the epilepsy models (1987), Humana Press, Clifton, NJ 277-320
13. Lueders H., Bustamante L., Zablow L., et al. Quantitative studies of spikes foci induced by minimal concentrations of penicillin. Electroencephalogr Clin Neurophysiol 48 (1980) 80-89
14. Kuczenski R., and Segal D.S. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors. Brain Res 822 (1999) 164-174
15. Conti L.H., Segal D.S., and Kuczenski R. Maintenance of amphetamine-induced stereotypy and locomotion requires ongoing dopamine receptor activation. Psychopharmacology 130 (1997) 183-188
16. Hoffman B.B., and Lefkowitz R.J. Catecholamines and simpathomimetic drugs. In: Goodman A., Wall T.W., Nies A.S., and Taylor P. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics (1990), Pergaman Prees, New York 187-220
17. Kozyrska C., and Zebrowska-Lupina I. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs. Pol J Pharmacol Pharm 35 (1983) 115-126
18. Baumeister A.A., and Francis J.L. Historical development of the dopamine hypothesis of schizophrenia. J Hist Neurosci 11 (2002) 265-277
19. De Erausquin G.A. Mechanism of molecular action of neuroleptics. Vertex 14 (2000) 36-44
20. Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry 47 (2002) 27-38
21. Halperin R., Guerin Jr. J.J., and Davis K.L. Chronic administration of three neuroleptics: effects of behavioural supersensitivity mediated by two different brain regions in the rat. Life Sci 33 (1983) 585-592
22. Torta R., and Monaco F. Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations. Epilepsia 43 Suppl. 2 (2002) 8-13
23. Kasture V.S., Deshmukh V.K., and Chopde C.T. Anticonvulsant and behavioral actions of triterpene isolated from Rubia cordifolia Linn. Indian J Exp Biol 38 (2000) 675-680
24. Yang P., Beasley A., Swann A., et al. Valproate modulates the expression of methylphenidate (ritalin) sensitization. Brain Res 874 (2000) 216-220
25. Meldrum B. Pharmacology of GABA. Clin Neuropharmacol 5 (1982) 293-316
26. Davies J.A. Mechanisms of action of antiepileptic drugs. Seizure 4 (1995) 267-271
27. LaRoche S.M., and Helmers S.L. The new antiepileptic drugs. JAMA 291 (2004) 605-614